Business
Gene-Editing Dispute Resolved: Prime Medicine Wins Arbitration
Prime Medicine has won an arbitration dispute against Beam Therapeutics over gene-editing technology, resolving a high-stakes legal battle between two well-funded biotech companies.
Coverage timeline — 1 article
STAT News
Prime Medicine said it had won an arbitration dispute against Beam Therapeutics, a clash that had pitted two well-backed gene-editing companies against each other.
2026-07-08 13:52 UTC